Binuclear dioxomolybdenum(VI) complexes of some tridentate ONS donor ligand containing [MoO2]2+ as the acceptor center: Synthesis, crystal structure, supramolecular architectures via hydrogen bonds, π-π stacking and DFT calculations

The vital role of ditopic N–N bridging ligands with different lengths in the formation of new binuclear dioxomolybdenum(vi) complexes: synthesis, crystal structures, supramolecular framework and protein binding studies

Role of bis-(pyridyl) and bis-(imidazole) auxiliary ligands in the formation of supramolecular architectures and BSA binding with new binuclear dioxomolybdenum(vi) complexes.

Molecular design and synthesis of new dithiocarbazate complexes; crystal structure, bioactivities and nano studies

The syntheses of a new set of metal complexes MoO2L'(CH3OH), VOL'(CH3O)(CH3OH), , , SnL'Cl2 and SnL'I2 with a new ligand (L = (2,2'(disulfanediylbis((ethylthio)methylene)bis(hydrazin-2-yl-1-ylidene)bis(methanylylidene)) diphenol; L' = S-ethyl-3-(2-hydroxyphenyl)methylenedithiocarbazate are described along with characterization by elemental analysis, mass spectrometry, spectroscopic (IR, 1H- and 13C-NMR) and TGA techniques. The crystal structures of compounds were determined by single crystal X-ray diffraction analysis and compared to powder X-ray diffraction (PXRD) patterns of the nano complexes obtained using ultrasonic methods. The PXRD results indicate that the compounds synthesized by ultrasonic methods have high crystallinity. The compounds were evaluated in an in vitro cytotoxicity study with two human cancer cell lines. The results of this study revealed that all complexes exhibit good cytotoxic activity when compared to the clinical drug, cisplatin. Interaction of the samples with human serum albumin (HSA) was investigated using fluorescence spectrophotometric methods and the Stern-Volmer quenching constant (K SV) and free energy changes (ΔG) were calculated at 298 K. The fluorescence quenching method is used to determine the number of binding sites (n) and association constants (K a) at the same temperatures.

Supramolecular frameworks of binuclear dioxomolybdenum(vi) complexes with ONS donor ligands using 4,4′-azopyridine as a pillar: crystal structure, DFT calculations and biological study

4,4′-Azpy is used as linker forming pillared dioxoMo(vi) complexes first time, biological activities are reported.